How long can you live after discovering brain cancer

For cancer patients, as soon as they hear the word cancer, they will be afraid and think of death. In fact, whether brain cancer is benign or malignant, it will have a certain impact on themselves, especially for those patients who have already developed the disease. They always feel that their lives have lost their meaning and they don’t know how long they can live. So how long can we live when we find brain cancer?

Many people are afraid of having a tumor in their brain, and patients are concerned about how long they can live with brain cancer. The survival period of brain cancer is related to many factors, and has a lot to do with the patient's own condition and treatment method. Patients with various brain cancers still have a certain survival period.

Among brain tumors, glioma has the highest incidence, accounting for about 40.49%, and the peak age of onset is 30-40 years old, or 10-20 years old. Generally speaking, the median survival of low-grade mixed glioma is about 6-7 years, and the 5-year and 10-year survival rates are 60% and 35% respectively. The median survival of high-grade mixed glioma is about 3-5 years, and the 5-year and 10-year survival rates are 55% and 30% respectively.

Medulloblastoma

Medulloblastoma is a malignant glioma of the posterior cranial fossa in children. It is a common intracranial tumor in children and also the most malignant intracranial glioma.

The average survival rate after tumor surgery is 0.9 years, and the prognosis of adults is better than that of children. Currently, most statistics show that the 5-year survival rate is above 30%, and the highest statistics are up to 80%. However, only a few can survive for more than ten years.

Meningioma survival

The incidence rate of meningioma is 19.2%, which is relatively high. Generally speaking, the age of onset is around 45 years old.

The average survival period after meningioma surgery is 9 years, and other reports have shown that the 10-year survival rate after meningioma surgery is 43% to 78%. Meningioma is a benign tumor, and its in situ recurrence phenomenon is noteworthy. Improving the level of surgery is very important to reduce the recurrence rate.

Brain cancer patients are indeed at risk of death in the middle and late stages. Everyone's physical condition is different, and the symptoms of the disease vary greatly, so it is impossible to predict how long a brain cancer patient can live. Generally, the survival rate can only be judged by the development of brain cancer, the patient's physical condition and the means of treatment. Patients must actively cooperate with treatment, pay attention to strengthening dietary nutrition, and maintain a good attitude.